The Crystal Structure of Engineered Nitroreductase NTR 2.0 and Impact of F70A and F108Y Substitutions on Substrate Specificity
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076633 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Abigail V Sharrock und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Victoria University of Wellington, Wellington 6012, New Zealand. Hauptthemen laut MEDLINE: Prodrugs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Royal Society of New Zealand, Health Research Council of New Zealand.
Abstract (Originalsprache)
Bacterial nitroreductase enzymes that convert prodrugs to cytotoxins are valuable tools for creating transgenic targeted ablation models to study cellular function and cell-specific regeneration paradigms. We recently engineered a nitroreductase (“NTR 2.0”) for substantially enhanced reduction of the prodrug metronidazole, which permits faster cell ablation kinetics, cleaner interrogations of cell function, ablation of previously recalcitrant cell types, and extended ablation paradigms useful for modelling chronic diseases. To provide insight into the enhanced enzymatic mechanism of NTR 2.0, we have solved the X-ray crystal structure at 1.85 Angstroms resolution and compared it to the parental enzyme, NfsB from Vibrio vulnificus. We additionally present a survey of reductive activity with eight alternative nitroaromatic substrates, to provide access to alternative ablation prodrugs, and explore applications such as remediation of dinitrotoluene pollutants. The predicted binding modes of four key substrates were investigated using molecular modelling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, Victoria University of Wellington, Wellington 6012, New Zealand.
- Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287, USA.
- Institute of Biochemistry, University of Vilnius, Saulėtekio 7, LT-10257 Vilnius, Lithuania.
- Te Aka Mātuatua-School of Science, University of Waikato, Hamilton 3240, New Zealand.
ORCID-Profile: Gintautas Bagdžiūnas, David F Ackerley
Förderung
- NIH HHS
- Royal Society of New Zealand
- Health Research Council of New Zealand
- Royal Society of New Zealand Marsden Fund
- US National Institutes of Health
Zitieren
APA
Sharrock, A. V., Mumm, J. S., Bagdžiūnas, G., Čėnas, N., Arcus, V. L., & Ackerley, D. F. (2023). The Crystal Structure of Engineered Nitroreductase NTR 2.0 and Impact of F70A and F108Y Substitutions on Substrate Specificity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076633
Vancouver
Sharrock AV, Mumm JS, Bagdžiūnas G, Čėnas N, Arcus VL, Ackerley DF. The Crystal Structure of Engineered Nitroreductase NTR 2.0 and Impact of F70A and F108Y Substitutions on Substrate Specificity. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076633
BibTeX
@article{Sharrock2023,
author = {Sharrock, Abigail V and Mumm, Jeff S and Bagdžiūnas, Gintautas and Čėnas, Narimantas and Arcus, Vickery L and Ackerley, David F},
title = {The Crystal Structure of Engineered Nitroreductase NTR 2.0 and Impact of F70A and F108Y Substitutions on Substrate Specificity},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076633}
}
EUVIMED